the main problem is that Koos can Lander can not find money to fund any clinical trial after IND. There has been no word yet on that supposed 3rd Q start of Hemaxellerate and it's clear as to why. Because Lander failed in finding money to fund the trial. Pure and simple.
News 
Market Data 
Discover 
